Search Results

Filter
  • 1-10 of  1,311 results for "%22AUSTRALIA%22"
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Persistence of Janus-kinase (JAK) inhibitors in rheumatoid arthritis: Australia wide study.

  • Authors : Scheepers L; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia. Electronic address: .; Yang Y

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Azetidines*

  • Source: Seminars in arthritis and rheumatism [Semin Arthritis Rheum] 2024 Feb; Vol. 64, pp. 152314. Date of Electronic Publication: 2023 Nov 24.Publisher: W.B. Saunders Country of Publication: United States NLM ID: 1306053 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The effect of TNF treatment uptake on incident hospital admission in Western Australia.

  • Authors : Kelty E; School of Population and Global Health, The University of Western Australia, 35 Stirling Hwy (M503), PerthCrawley, WA, 6009, Australia. .; Quintrell E

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/pharmacology ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy ; Hospitalization*/Hospitalization*/Hospitalization*/statistics & numerical data

  • Source: Pediatric rheumatology online journal [Pediatr Rheumatol Online J] 2023 Mar 28; Vol. 21 (1), pp. 29. Date of Electronic Publication: 2023 Mar 28.Publisher: BioMed Central Country of Publication: England NLM ID: 101248897 Publication Model: Electronic Cited Medium: Internet ISSN: 1546-0096

Record details

×
Academic Journal

A novel method to monitor rheumatoid arthritis prevalence using hospital and medication databases.

  • Authors : Koller-Smith L; Frazer Institute, The University of Queensland, Translational Research Institute (TRI), Level 7, 37 Kent St, Woolloongabba, QLD, 4102, Australia.; Florance and Cope Professorial Department of Rheumatology, Royal North Shore Hospital and Kolling Institute and Sydney MSK Flagship, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/epidemiology ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis

  • Source: Arthritis research & therapy [Arthritis Res Ther] 2024 Jul 16; Vol. 26 (1), pp. 133. Date of Electronic Publication: 2024 Jul 16.Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362

Record details

×
Academic Journal

Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.

  • Authors : Littlejohn G; OPAL Rheumatology Ltd, Sydney, NSW, Australia. .; Monash University, Clayton, VIC, Australia. .

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Remission Induction*

  • Source: Clinical rheumatology [Clin Rheumatol] 2024 Jun; Vol. 43 (6), pp. 1823-1832. Date of Electronic Publication: 2024 Apr 18.Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949

Record details

×
Academic Journal

Rheumatology specialist care delivered at the Southern QLD Centre of Excellence in Aboriginal and Torres Strait Islander Primary Health Care.

  • Authors : Grosman S; Rheumatology Department, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia.; Tesiram J

Subjects: Rheumatology* ; Health Services, Indigenous* ; Arthritis, Rheumatoid*

  • Source: Internal medicine journal [Intern Med J] 2024 Jan; Vol. 54 (1), pp. 115-120. Date of Electronic Publication: 2023 Jun 16.Publisher: Blackwell Science Asia Country of Publication: Australia NLM ID: 101092952 Publication Model: Print-Electronic

Record details

×
Academic Journal

Three- and five-year outcomes of an inception cohort of Australian children with juvenile idiopathic arthritis.

  • Authors : Tiller G; Department of Rheumatology, The Royal Children's Hospital, Melbourne, Victoria, Australia.; Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Subjects: Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/drug therapy ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/epidemiology ; Arthritis, Juvenile*/Arthritis, Juvenile*/Arthritis, Juvenile*/diagnosis

  • Source: International journal of rheumatic diseases [Int J Rheum Dis] 2024 May; Vol. 27 (5), pp. e15189.Publisher: Wiley on behalf of the Asia Pacific League of Associations for Rheumatology Country of Publication: England NLM ID: 101474930 Publication Model:

Record details

×
Academic Journal

Real-world evaluation of effectiveness, persistence, and usage patterns of monotherapy and combination therapy tofacitinib in treatment of rheumatoid arthritis in Australia.

  • Authors : Bird P; University of New South Wales, Kensington, New South Wales, Australia.; Littlejohn G

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy; Australia

  • Source: Clinical rheumatology [Clin Rheumatol] 2022 Jan; Vol. 41 (1), pp. 53-62. Date of Electronic Publication: 2021 Aug 09.Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949

Record details

×
Editorial & Opinion

Screening for hydroxychloroquine retinopathy in Australia.

  • Authors : Fung AT; University of Sydney, Sydney, NSW.; Macquarie University Hospital, MQ Health, Sydney, NSW.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Retinal Diseases*/Retinal Diseases*/Retinal Diseases*/chemically induced ; Retinal Diseases*/Retinal Diseases*/Retinal Diseases*/diagnosis

  • Source: The Medical journal of Australia [Med J Aust] 2021 Nov 01; Vol. 215 (9), pp. 434. Date of Electronic Publication: 2021 Oct 08.Publisher: Australasian Medical Publishing Co Country of Publication: Australia NLM ID: 0400714 Publication Model:

Record details

×
Academic Journal

Real-world evaluation of effectiveness, persistence, and usage patterns of tofacitinib in treatment of rheumatoid arthritis in Australia.

  • Authors : Bird P; OPAL Rheumatology Ltd, Sydney, New South Wales, Australia.; University of New South Wales, Kensington, New South Wales, Australia.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy; Aged

  • Source: Clinical rheumatology [Clin Rheumatol] 2020 Sep; Vol. 39 (9), pp. 2545-2551. Date of Electronic Publication: 2020 Mar 10.Publisher: Springer Country of Publication: Germany NLM ID: 8211469 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1434-9949

Record details

×
  • 1-10 of  1,311 results for "%22AUSTRALIA%22"